Cyclin-Dependent Kinase-Like 5 (CDKL5) (C-Term) antibody
| Antigen | Cyclin-Dependent Kinase-Like 5 (CDKL5) |
| Synonyms | ISSX, STK9, Stk9, BC038161, CDKL5, issx, stk9 |
| Binding Site |
Alternatives C-Term |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Western Blotting (WB), Immunohistochemistry (IHC), ELISA |
![]() |
1 reference available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN391362 |
| Quantity | 0.1 mg (0.25 mg/ml) |
| Price | 280.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Alternative name | CDKL5 (STK9) |
| Gene ID | 6792 |
| UniProt | O76039 |
| Immunogen | This CDKL5 (STK9) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 990~1019 amino acids from the C-terminal region of human STK9. |
| Isotype | Ig |
| Description | Other names: Serine/threonine protein kinase 9, Cyclin-dependent kinase-like 5 |
| Characteristics | Purified Rabbit Polyclonal Antibody (Pab) |
| Specificity | This CDKL5 (STK9) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 990~1019 amino acids from the C-terminal region of human STK9. |
| Molecular Weight | 115537 DA |
| Comments |
Background: Defects in STK9, a dual-specificity serine/threonine kinase, are a cause of atypical Rett syndrome. Rett syndrome is an X-linked dominant disease. It is a progressive neurologic developmental disorder and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation, and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. Rett syndrome due to CDKL5-associated mutations is characterized by a severe early-onset phenotype and atypical features such as infantile spasms. |
Application Details
| Application Notes | The suggested dilution is: ELISA~~1:1,000 Western blotting~~1:100~500 Immunohistochemistry~~1:10~50 |
| Concentration | 0.25 mg/ml |
| Purification | Purified |
| Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. |
| Storage | Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles |
| Research Area | Phospho-specific antibodies, Cell Signaling, Protein Modifications, Neurology, Cell Structure |
| Restrictions | For Research Use only |
Images
Publications
| Product |
Montini, Andolfi, Caruso et al.: "Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region." in: Genomics, Vol. 51, Issue 3, pp. 427-33, 1998 (PubMed).
|
Alternatives
| Hosts | Rabbit (23) |
| Reactivities | Human (23), Cow (Bovine) (18), Dog (Canine) (18), Horse (Equine) (18), Mouse (Murine) (18), Pig (Porcine) (18), Rat (Rattus) (18), Sheep (Ovine) (18) |
| Applications | Immunofluorescence (IF) (15), Western Blotting (WB) (8), ELISA (5), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (5), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (3), Immunoelectron Microscopy (IEM) (1) |
| Conjugates | Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Biotin (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), FITC (1), Gold (1), HRP (1), PE (1), PE-Cy3 (1), PE-Cy5 (1), PE-Cy5.5 (1), PE-Cy7 (1), Un-conjugated (1) |
| Epitopes | AA 401-500 (18), C-Term (4) |




Alternatives